Abstract
Annuloplasty is the cornerstone of surgical mitral valve repair. A percutaneous transvenous catheter-based approach for mitral valve repair was tested by placing a novel annuloplasty device in the coronary sinus of sheep with acute ischemic mitral regurgitation. Mitral regurgitation was reduced from 3-4+ to 0-1+ in all animals (P < 0.03). The annuloplasty functioned by reducing septal-lateral mitral annular diameter (30 +/- 2.1 mm preinsertion vs. 24 +/- 1.7 mm postinsertion; P < 0.03). These preliminary experiments demonstrate that percutaneous mitral annuloplasty is feasible. Further study is necessary to demonstrate long-term safety and efficacy of this novel approach.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Blood Pressure / physiology
-
Coronary Angiography
-
Coronary Vessels / diagnostic imaging
-
Coronary Vessels / pathology
-
Coronary Vessels / surgery
-
Device Removal
-
Disease Models, Animal
-
Echocardiography
-
Electrocardiography
-
Feasibility Studies
-
Heart Rate / physiology
-
Heart Valve Prosthesis Implantation* / instrumentation
-
Heart Ventricles / diagnostic imaging
-
Heart Ventricles / surgery
-
Mitral Valve / diagnostic imaging
-
Mitral Valve / surgery*
-
Mitral Valve Insufficiency / diagnosis
-
Mitral Valve Insufficiency / physiopathology
-
Mitral Valve Insufficiency / surgery
-
Models, Cardiovascular
-
Myocardial Ischemia / diagnosis
-
Myocardial Ischemia / physiopathology
-
Myocardial Ischemia / surgery
-
Sheep
-
Stroke Volume / physiology